CD16/IL-15/CD33 (161533) Tri specific Killer Engagers (TriKEs) for the Treatment of High Risk Myelodysplastic Syndromes, Refractory/Relapsed Acute Myeloid Leukemia and Advanced Systemic Mastocytosis

  • Cooley, Sarah A (PI)

Project: Research project

Project Details

Description

CD16/IL-15/CD33 (161533) Tri specific Killer Engagers (TriKEs) for the Treatment of High Risk Myelodysplastic Syndromes, Refractory/Relapsed Acute Myeloid Leukemia and Advanced Systemic Mastocytosis
StatusActive
Effective start/end date6/1/171/31/24

Funding

  • GT BIOPHARMA, INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.